Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia

acute myeloid leukemia, acute myeloid leukemia post cytotoxic therapy, blast phase chronic myeloid leukemia, bcr-abl1 positive, myelodysplastic syndrome, recurrent adult acute myeloid leukemia, recurrent chronic myeloid leukemia, bcr-abl1 positive, refractory acute myeloid leukemia, refractory chronic myeloid leukemia, bcr-abl1 positive, secondary acute myeloid leukemia, interventional, phase1